Table 3. Characteristics of extracorporeal membrane oxygenation use (N = 30).a .
| Characteristic | Result |
|---|---|
| ECMO indication criteria | |
| Hypoxemia | 25 (83.3) |
| Hypercapnia | 01 (03.3) |
| Both | 04 (13.3) |
| Diameter of inflow cannula. Fr | 25 [23-29]b |
| Diameter of outflow cannula. Fr | 19 [19-21]b |
| ECMO parameters on ECMO Day 1 | |
| ECMO blood flow. L/min | 4.5 [4.2-5.0] |
| Sweep gas flow. L/min | 5 [4-6]c |
| FmO2. % | 100 [100-100] |
| Ventilation parameters on ECMO Day 1 | |
| Fio2. % | 30 [30-40] |
| PEEP. cmH2O | 10 [8-10] |
| RR. breaths/min | 10 [10-12] |
| Plateau pressure. cmH2O | 23 [21-26]d |
| Driving pressure. cmH2O | 14 [12-15]d |
| Drug use | |
| Antibiotics for any reason | 29 (96.7) |
| Corticosteroids | 30 (100.0) |
| Anticoagulation drugs | 29 (96.7) |
| Vasoactive drugs | 24 (80.0) |
| Tracheostomy during ECMO | 14 (46.7) |
| Renal replacement therapy during ECMO | 11 (36.7) |
ECMO: extracorporeal membrane oxygenation; and FmO2: membrane fraction of oxygen. aValues expressed as n (%) of patients or median [IQR]. bn = 28. cn = 29. dn = 21.